These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 20008931)

  • 1. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
    Mu P; Han YC; Betel D; Yao E; Squatrito M; Ogrodowski P; de Stanchina E; D'Andrea A; Sander C; Ventura A
    Genes Dev; 2009 Dec; 23(24):2806-11. PubMed ID: 20008931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microRNA polycistron as a potential human oncogene.
    He L; Thomson JM; Hemann MT; Hernando-Monge E; Mu D; Goodson S; Powers S; Cordon-Cardo C; Lowe SW; Hannon GJ; Hammond SM
    Nature; 2005 Jun; 435(7043):828-33. PubMed ID: 15944707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
    Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
    Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
    [No Abstract]   [Full Text] [Related]  

  • 5. B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice.
    Sandhu SK; Fassan M; Volinia S; Lovat F; Balatti V; Pekarsky Y; Croce CM
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18208-13. PubMed ID: 24145403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas.
    Jeong D; Kim J; Nam J; Sun H; Lee YH; Lee TJ; Aguiar RC; Kim SW
    Leukemia; 2015 Sep; 29(9):1868-74. PubMed ID: 25915824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.
    Arrate MP; Vincent T; Odvody J; Kar R; Jones SN; Eischen CM
    Cancer Res; 2010 Jul; 70(14):6083-92. PubMed ID: 20587524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth.
    Mihailovich M; Bremang M; Spadotto V; Musiani D; Vitale E; Varano G; Zambelli F; Mancuso FM; Cairns DA; Pavesi G; Casola S; Bonaldi T
    Nat Commun; 2015 Nov; 6():8725. PubMed ID: 26555894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread microRNA repression by Myc contributes to tumorigenesis.
    Chang TC; Yu D; Lee YS; Wentzel EA; Arking DE; West KM; Dang CV; Thomas-Tikhonenko A; Mendell JT
    Nat Genet; 2008 Jan; 40(1):43-50. PubMed ID: 18066065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
    Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
    Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
    Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D
    Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.
    Musilova K; Mraz M
    Leukemia; 2015 May; 29(5):1004-17. PubMed ID: 25541152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.
    Lwin T; Zhao X; Cheng F; Zhang X; Huang A; Shah B; Zhang Y; Moscinski LC; Choi YS; Kozikowski AP; Bradner JE; Dalton WS; Sotomayor E; Tao J
    J Clin Invest; 2013 Nov; 123(11):4612-26. PubMed ID: 24216476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis.
    Hezaveh K; Kloetgen A; Bernhart SH; Mahapatra KD; Lenze D; Richter J; Haake A; Bergmann AK; Brors B; Burkhardt B; Claviez A; Drexler HG; Eils R; Haas S; Hoffmann S; Karsch D; Klapper W; Kleinheinz K; Korbel J; Kretzmer H; Kreuz M; Küppers R; Lawerenz C; Leich E; Loeffler M; Mantovani-Loeffler L; López C; McHardy AC; Möller P; Rohde M; Rosenstiel P; Rosenwald A; Schilhabel M; Schlesner M; Scholz I; Stadler PF; Stilgenbauer S; Sungalee S; Szczepanowski M; Trümper L; Weniger MA; Siebert R; Borkhardt A; Hummel M; Hoell JI;
    Haematologica; 2016 Nov; 101(11):1380-1389. PubMed ID: 27390358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc-mediated overexpression of miR-17-92 suppresses replication of hepatitis B virus in human hepatoma cells.
    Jung YJ; Kim JW; Park SJ; Min BY; Jang ES; Kim NY; Jeong SH; Shin CM; Lee SH; Park YS; Hwang JH; Kim N; Lee DH
    J Med Virol; 2013 Jun; 85(6):969-78. PubMed ID: 23532756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.
    Inomata M; Tagawa H; Guo YM; Kameoka Y; Takahashi N; Sawada K
    Blood; 2009 Jan; 113(2):396-402. PubMed ID: 18941111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Emu-c-myc or N-myc transgenes.
    Linardopoulos S; Silva S; Klein G; Balmain A
    Int J Cancer; 2000 Dec; 88(6):920-7. PubMed ID: 11093815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Biogenesis of pri-miR-17∼92 Reveals Hierarchy and Competition among Polycistronic MicroRNAs.
    Donayo AO; Johnson RM; Tseng HW; Izreig S; Gariepy A; Mayya VK; Wu E; Alam R; Lussier C; Jones RG; Duchaine TF
    Mol Cell; 2019 Jul; 75(2):340-356.e10. PubMed ID: 31253575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.
    Tao J; Zhao X; Tao J
    Cell Cycle; 2014; 13(2):191-8. PubMed ID: 24394940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.